Copertina

Dual Role of Exosomes in Parkinson's Disease: Adenine Exerts a Beneficial Effect

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Lei Chen, Yi‐Ting Shao, Ji Geng, Hua Liu, Qing‐Shan Liu, Yong Cheng, Ting Sun
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	CNS Neuroscience & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

GSDMD ‐Deficient G‐ MDSCs Exert Profoundly Suppressive Activity to Relieve MPTP ‐Induced Parkinson's Disease
di: Qi Wu, et al.
Pubblicazione: (2025)

Novel Insights Into DLAT's Role in Alzheimer's Disease‐Related Copper Toxicity Through Microglial Exosome Dynamics
di: Xiang Ma, et al.
Pubblicazione: (2024)

Novel Insights Into the Association Between Parkinson's Disease and Constipation: Role of SHMT2 as a Promising Biomarker
di: Jiehua Su, et al.
Pubblicazione: (2026)

Data‐Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness
di: Jian‐Yong Wang, et al.
Pubblicazione: (2025)

Histamine Modulation of the Basal Ganglia Circuitry in the Motor Symptoms of Parkinson's Disease
di: Hui‐Xian Zhu, et al.
Pubblicazione: (2025)

Novel Insights Into the Causal Effects and Shared Genetics Between Body Fat and Parkinson Disease
di: Qian Zhao, et al.
Pubblicazione: (2024)

MCC ‐135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus
di: Chaoning Liu, et al.
Pubblicazione: (2026)

Monoamine Loss and Functional Connectivity Alterations in Patients With Parkinson's Disease and Depression
di: Bao‐Lei Xu, et al.
Pubblicazione: (2025)

What We Know About TMEM175 in Parkinson's Disease
di: Jing Wang, et al.
Pubblicazione: (2025)

Electrophysiological Alterations in the Progression of Parkinson's Disease and the Therapeutic Effect of Tetrabenazine on Rats With Levodopa‐Induced Dyskinesia
di: Yuewei Bi, et al.
Pubblicazione: (2025)

Alpinetin Targets Mitophagy Pathways to Mitigate Parkinson's Disease Progression
di: Zilu Shen, et al.
Pubblicazione: (2025)

Exploratory Analysis of the Association Between Plasma Ceramide Alterations and Cognitive Dysfunction in Parkinson's Disease
di: Xu Liu, et al.
Pubblicazione: (2024)

Biological Effects of Dietary Restriction on Alzheimer's Disease: Experimental and Clinical Investigations
di: Zijiao Liu, et al.
Pubblicazione: (2025)

SYNGR3 Accelerates α‐Synuclein Aggregation and Neurodegeneration in Parkinson's Disease
di: Xin Wang, et al.
Pubblicazione: (2026)

The Progression of NUS1‐Associated Parkinson's Disease and the Diagnostic Potential of Plasma NgBR
di: Lizhi Li, et al.
Pubblicazione: (2025)

High‐Intensity Alternating Current Stimulation as an Add‐On to Multidisciplinary Intensive Rehabilitation for Parkinson's Disease: A Randomized Controlled Trial
di: Ting‐ting Hou, et al.
Pubblicazione: (2026)

Transcriptomic Insights Into Alzheimer's Disease: Differentially Expressed Genes and Cholesterol Metabolism
di: Rui Sun, et al.
Pubblicazione: (2026)

Cerebellar and Brainstem White Matter Geometric Alterations in Multiple System Atrophy: A DFA ‐Based Biomarker for Disease Staging
di: Hua Zhu, et al.
Pubblicazione: (2025)

Clinical Effect on Cortical Reactivity of Theta Burst Versus High‐Frequency Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease: A TMS ‐ EEG Study
di: Jiajing Wu, et al.
Pubblicazione: (2025)

Genetic Analysis of Neurite Outgrowth Inhibitor‐Associated Genes in Parkinson's Disease: A Cross‐Sectional Cohort Study
di: Xiurong Huang, et al.
Pubblicazione: (2024)

Impact and Mechanisms of Action of BDNF on Neurological Disorders, Cancer, and Cardiovascular Diseases
di: Min Lei, et al.
Pubblicazione: (2024)

Targeting mGluR2 /3 Signaling With LY341495 Restores Dentate Gyrus Function and Cognitive Performance in a Male Mouse Model of Alzheimer's Disease
di: Cui‐Ping Chen, et al.
Pubblicazione: (2026)

Multi‐Target Repetitive Transcranial Magnetic Stimulation Improves Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial
di: Zixuan Zhang, et al.
Pubblicazione: (2025)

Association between plasma Netrin‐1 levels and motor and nonmotor symptoms in Parkinson's disease
di: Ye Hua, et al.
Pubblicazione: (2024)

CPCGI Alleviates Neural Damage by Modulating Microglial Pyroptosis After Traumatic Brain Injury
di: Lu‐Lu Yu, et al.
Pubblicazione: (2025)

EXPRESSION OF CONCERN : Beneficial Effects of Co‐Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism
Pubblicazione: (2024)

Groundbreaking Insights Into SIRT1 / NRF2 ‐Mediated Ferroptosis Inhibition by Resveratrol in Parkinson's Disease Models
di: Qian Zheng, et al.
Pubblicazione: (2025)

Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications
di: Shuangjie Qian, et al.
Pubblicazione: (2026)

Comparing the Risk of Epilepsy in Patients With Simple Congenital Heart Diseases: A Prospective Cohort Study
di: Lei Chen, et al.
Pubblicazione: (2025)

PV and SST neurons in the anterior cingulate cortex regulate social disorders in adulthood induced by sensory abnormalities in childhood
di: Xiang‐Dong Wan, et al.
Pubblicazione: (2024)

Alterations in cortical volume and complexity in Parkinson's disease with depression
di: Jiaying Yuan, et al.
Pubblicazione: (2024)

Anatomical Determinants of STN Coordinate Shift in Idiopathic Parkinson's Disease DBS Surgery
di: Ozan Hasimoglu, et al.
Pubblicazione: (2025)

Unraveling the Relation of Parkinson's Disease and Metabolites: A Combined Analysis of Stool and Plasma Metabolites Based on Untargeted Metabolomics Technology
di: Sufang Liu, et al.
Pubblicazione: (2025)

Predicting Long‐Term Depression Progression in Parkinson's Disease: A Machine‐Learning Survival Analysis and Risk Score
di: Defu Liu, et al.
Pubblicazione: (2026)

Plasma‐Derived Exosomal i‐tRF‐LeuCAA as Biomarker for Glioma Diagnosis and Promoter of Epithelial‐Mesenchymal Transition via TPM4 Regulation
di: Hongyu Liu, et al.
Pubblicazione: (2025)

Levodopa and Plant‐Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives
di: Emre Aktaş, et al.
Pubblicazione: (2025)

Fecal microbiota from patients with Parkinson's disease intensifies inflammation and neurodegeneration in A53T mice
di: Huijia Yang, et al.
Pubblicazione: (2024)

Peripheral Signatures of Multidimensional Pathology in Symptomatic and Asymptomatic Creutzfeldt–Jakob Disease
di: Zhong‐Yun Chen, et al.
Pubblicazione: (2026)

Vof16‐miR‐185‐5p‐GAP43 network improves the outcomes following spinal cord injury via enhancing self‐repair and promoting axonal growth
di: Yue Hu, et al.
Pubblicazione: (2024)

Abnormalities of Hippocampal Subfields in Individuals With Acute Carbon Monoxide Poisoning
di: Mengyue Tang, et al.
Pubblicazione: (2025)